help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Repaske, D. R.
Right arrow Articles by Phillips, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Repaske, D. R.
Right arrow Articles by Phillips, J. A., III
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ALANINE
*VASOPRESSIN
Medline Plus Health Information
*Diabetes Insipidus
*Diabetes Medicines
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 1 51-56
Copyright © 1997 by The Endocrine Society


Clinical Studies

Heterogeneity in Clinical Manifestation of Autosomal Dominant Neurohypophyseal Diabetes Insipidus Caused by a Mutation Encoding Ala-1->Val in the Signal Peptide of the Arginine Vasopressin/Neurophysin II/Copeptin Precursor1

David R. Repaske, Rita Medlej, Ebrû K. Gültekin, M. R. S. Krishnamani, George Halaby, James W. Findling and John A. Phillips, III

Division of Endocrinology, Children’s Hospital Medical Center (D.R.R., E.K.G), Cincinnati, Ohio 45229-3039; the Department of Endocrinology, Hotel-Dieu de France (R.M., G.H.), Beirut, Lebanon; Department of Pediatrics, Vanderbilt University School of Medicine (M.R.S.K., J.A.P), Nashville, Tennessee 37232-2578; and the Division of Endocrinology, St. Luke’s Medical Center (J.W.F.), Milwaukee, Wisconsin 53215

Address all correspondence and requests for reprints to: David Repaske, Ph.D., M.D., NWM-1 TCHRF, Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio 45229-3039. E-mail: repaskdr{at}ucunix.san.uc.edu

Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) is a familial form of diabetes insipidus due to progressive vasopressin deficiency with onset typically at 1–6 yr of age. Affected individuals demonstrate specific degeneration of the vasopressinergic magnocellular neurons in the hypothalamic supraoptic and paraventricular nuclei and loss of the posterior pituitary bright spot on magnetic resonance imaging. The genetic locus of ADNDI is the arginine vasopressin-neurophysin II (AVP-NPII) gene. Mutations that cause ADNDI have been found to occur both within the signal peptide of the prepro-AVP-NPII precursor and within the coding sequence for neurophysin II, but not within the coding sequence for AVP itself. We evaluated the AVP-NPII genes in two independent families with ADNDI and identified a mutation (C280->T) in the coding sequence for the signal peptide of the prepro-AVP-NPII precursor in both families. This mutation encodes an Ala->Val substitution at the C-terminus of the signal peptide (-1 amino acid). This mutation predicts the complete inability of signal peptidase to cleave the signal peptide from the preproprecursor and supports the hypothesis that the progressive neural degeneration that underlies ADNDI is caused by accumulation of malprocessed precursor. However, considerable heterogeneity in the age of onset (1–28 yr of age) and the severity of diabetes insipidus among affected members of these two families suggests that additional factors modulate the rate and extent of progression of the neurodegeneration that results from this one specific ADNDI mutation.




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Hayashi, H. Arima, N. Ozaki, Y. Morishita, M. Hiroi, N. Ozaki, H. Nagasaki, N. Kinoshita, M. Ueda, A. Shiota, et al.
Progressive polyuria without vasopressin neuron loss in a mouse model for familial neurohypophysial diabetes insipidus
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1641 - R1649.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Ye, X. Li, Y. Chen, H. Sun, W. Wang, T. Su, L. Jiang, B. Cui, and G. Ning
Autosomal Dominant Neurohypophyseal Diabetes Insipidus with Linkage to Chromosome 20p13 but without Mutations in the AVP-NPII Gene
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4388 - 4393.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. T. Wahlstrom, M. J. Fowler, W. E. Nicholson, and W. J. Kovacs
A Novel Mutation in the Preprovasopressin Gene Identified in a Kindred with Autosomal Dominant Neurohypophyseal Diabetes Insipidus
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1963 - 1968.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. P. Mahoney, E. Weinberger, C. Bryant, M. Ito, J. L. Jameson, and M. Ito
Effects of Aging on Vasopressin Production in a Kindred with Autosomal Dominant Neurohypophyseal Diabetes Insipidus Due to the {Delta}E47 Neurophysin Mutation
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 870 - 876.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Nijenhuis, E. L. T. van den Akker, R. Zalm, A. A. M. Franken, A. P. Abbes, H. Engel, D. de Wied, and J. P. H. Burbach
Familial Neurohypophysial Diabetes Insipidus in a Large Dutch Kindred: Effect of the Onset of Diabetes on Growth in Children and Cell Biological Defects of the Mutant Vasopressin Prohormone
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3410 - 3420.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. P. H. Burbach, S. M. Luckman, D. Murphy, and H. Gainer
Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System
Physiol Rev, July 1, 2001; 81(3): 1197 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. P. Abbes, B. Bruggeman, E. L.T. van den Akker, M. R. de Groot, A. A.M. Franken, V. R. Drexhage, and H. Engel
Identification of Two Distinct Mutations at the Same Nucleotide Position, Concomitantly with a Novel Polymorphism in the Vasopressin-Neurophysin II Gene (AVP-NP II) in Two Dutch Families with Familial Neurohypophyseal Diabetes Insipidus
Clin. Chem., October 1, 2000; 46(10): 1699 - 1702.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Calvo, J. R. Bilbao, A. Rodríguez, M. D. Rodríguez-Arnao, and L. Castaño
Molecular Analysis in Familial Neurohypophyseal Diabetes Insipidus: Early Diagnosis of an Asymptomatic Carrier
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3351 - 3354.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Siggaard, S. Rittig, T. J. Corydon, P. H. Andreasen, T. G. Jensen, B. S. Andresen, G. L. Robertson, N. Gregersen, L. Bolund, and E. B. Pedersen
Clinical and Molecular Evidence of Abnormal Processing and Trafficking of the Vasopressin Preprohormone in a Large Kindred with Familial Neurohypophyseal Diabetes Insipidus due to A Signal Peptide Mutation
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2933 - 2941.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Nijenhuis, R. Zalm, and J. P. H. Burbach
Mutations in the Vasopressin Prohormone Involved in Diabetes Insipidus Impair Endoplasmic Reticulum Export but Not Sorting
J. Biol. Chem., July 23, 1999; 274(30): 21200 - 21208.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. D. Willcutts, E. Felner, and P. C. White
Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin
Hum. Mol. Genet., July 1, 1999; 8(7): 1303 - 1307.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Heppner, J. Kotzka, C. Bullmann, W. Krone, and D. Müller-Wieland
Identification of Mutations of the Arginine Vasopressin-Neurophysin II Gene in Two Kindreds with Familial Central Diabetes Insipidus
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 693 - 696.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society